MARINEMAX INC (HZO) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HZO - US5679081084 - Common Stock
27.55 USD
+1.16 (+4.4%)
27.55 USD
0 (0%)
Taking everything into account, HZO scores 3 out of 10 in our fundamental rating. HZO was compared to 122 industry peers in the Specialty Retail industry. HZO may be in some trouble as it scores bad on both profitability and health. HZO is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year HZO was profitable.
HZO had a positive operating cash flow in the past year.
Of the past 5 years HZO 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: HZO reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of -1.28%, HZO is in line with its industry, outperforming 41.80% of the companies in the same industry.
HZO's Return On Equity of -3.38% is in line compared to the rest of the industry. HZO outperforms 49.18% of its industry peers.
HZO has a Return On Invested Capital (3.34%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for HZO is significantly below the industry average of 12.14%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.28% | ||
| ROE | -3.38% | ||
| ROIC | 3.34% |
ROA(3y)1.56%
ROA(5y)6.94%
ROE(3y)4.15%
ROE(5y)12.76%
ROIC(3y)4.73%
ROIC(5y)10.19%
1.3 Margins
Looking at the Operating Margin, with a value of 4.46%, HZO is in the better half of the industry, outperforming 63.11% of the companies in the same industry.
In the last couple of years the Operating Margin of HZO has declined.
Looking at the Gross Margin, with a value of 32.49%, HZO is doing worse than 61.48% of the companies in the same industry.
HZO's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.46% | ||
| PM (TTM) | N/A | ||
| GM | 32.49% |
OM growth 3Y-27.03%
OM growth 5Y-9.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.37%
GM growth 5Y4.23%
2. Health
2.1 Basic Checks
HZO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for HZO has been reduced compared to 1 year ago.
HZO has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for HZO is higher compared to a year ago.
2.2 Solvency
HZO has an Altman-Z score of 1.82. This is not the best score and indicates that HZO is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.82, HZO perfoms like the industry average, outperforming 44.26% of the companies in the same industry.
The Debt to FCF ratio of HZO is 92.74, which is on the high side as it means it would take HZO, 92.74 years of fcf income to pay off all of its debts.
HZO has a Debt to FCF ratio of 92.74. This is comparable to the rest of the industry: HZO outperforms 41.80% of its industry peers.
HZO has a Debt/Equity ratio of 1.14. This is a high value indicating a heavy dependency on external financing.
HZO's Debt to Equity ratio of 1.14 is in line compared to the rest of the industry. HZO outperforms 40.98% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 92.74 | ||
| Altman-Z | 1.82 |
ROIC/WACC0.38
WACC8.8%
2.3 Liquidity
HZO has a Current Ratio of 1.20. This is a normal value and indicates that HZO is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of HZO (1.20) is comparable to the rest of the industry.
A Quick Ratio of 0.32 indicates that HZO may have some problems paying its short term obligations.
HZO's Quick ratio of 0.32 is on the low side compared to the rest of the industry. HZO is outperformed by 68.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.32 |
3. Growth
3.1 Past
The earnings per share for HZO have decreased strongly by -59.91% in the last year.
Measured over the past years, HZO shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -24.26% on average per year.
HZO shows a decrease in Revenue. In the last year, the revenue decreased by -5.01%.
Measured over the past years, HZO shows a quite strong growth in Revenue. The Revenue has been growing by 8.87% on average per year.
EPS 1Y (TTM)-59.91%
EPS 3Y-54.22%
EPS 5Y-24.26%
EPS Q2Q%-116.67%
Revenue 1Y (TTM)-5.01%
Revenue growth 3Y0.02%
Revenue growth 5Y8.87%
Sales Q2Q%-1.95%
3.2 Future
Based on estimates for the next years, HZO will show a very strong growth in Earnings Per Share. The EPS will grow by 50.07% on average per year.
HZO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.37% yearly.
EPS Next Y5.9%
EPS Next 2Y39.26%
EPS Next 3Y50.07%
EPS Next 5YN/A
Revenue Next Year1.95%
Revenue Next 2Y2.98%
Revenue Next 3Y3.37%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 32.41 indicates a quite expensive valuation of HZO.
Based on the Price/Earnings ratio, HZO is valued a bit cheaper than 61.48% of the companies in the same industry.
When comparing the Price/Earnings ratio of HZO to the average of the S&P500 Index (27.00), we can say HZO is valued slightly more expensively.
With a Price/Forward Earnings ratio of 30.61, HZO can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HZO is on the same level as its industry peers.
HZO's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 23.70.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.41 | ||
| Fwd PE | 30.61 |
4.2 Price Multiples
HZO's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. HZO is cheaper than 88.52% of the companies in the same industry.
HZO's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 50.45 | ||
| EV/EBITDA | 5.24 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HZO does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as HZO's earnings are expected to grow with 50.07% in the coming years.
PEG (NY)5.49
PEG (5Y)N/A
EPS Next 2Y39.26%
EPS Next 3Y50.07%
5. Dividend
5.1 Amount
No dividends for HZO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
27.55
+1.16 (+4.4%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners97.97%
Inst Owner Change0%
Ins Owners2.85%
Ins Owner Change9.65%
Market Cap602.52M
Revenue(TTM)2.31B
Net Income(TTM)-31.63M
Analysts81.54
Price Target31.47 (14.23%)
Short Float %22.26%
Short Ratio13.22
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.75%
Min EPS beat(2)-59.12%
Max EPS beat(2)68.62%
EPS beat(4)3
Avg EPS beat(4)70.61%
Min EPS beat(4)-59.12%
Max EPS beat(4)189.48%
EPS beat(8)4
Avg EPS beat(8)16.56%
EPS beat(12)5
Avg EPS beat(12)7.14%
EPS beat(16)9
Avg EPS beat(16)12.31%
Revenue beat(2)1
Avg Revenue beat(2)-4.93%
Min Revenue beat(2)-12.47%
Max Revenue beat(2)2.61%
Revenue beat(4)2
Avg Revenue beat(4)-1.55%
Min Revenue beat(4)-12.47%
Max Revenue beat(4)8.06%
Revenue beat(8)4
Avg Revenue beat(8)-1.17%
Revenue beat(12)6
Avg Revenue beat(12)0.01%
Revenue beat(16)9
Avg Revenue beat(16)0.51%
PT rev (1m)-6.09%
PT rev (3m)-9.69%
EPS NQ rev (1m)-61.23%
EPS NQ rev (3m)-134.17%
EPS NY rev (1m)-4.61%
EPS NY rev (3m)-51.94%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)-2.98%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-1.79%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.41 | ||
| Fwd PE | 30.61 | ||
| P/S | 0.26 | ||
| P/FCF | 50.45 | ||
| P/OCF | 8.28 | ||
| P/B | 0.64 | ||
| P/tB | 1.61 | ||
| EV/EBITDA | 5.24 |
EPS(TTM)0.85
EY3.09%
EPS(NY)0.9
Fwd EY3.27%
FCF(TTM)0.55
FCFY1.98%
OCF(TTM)3.33
OCFY12.08%
SpS105.59
BVpS42.85
TBVpS17.14
PEG (NY)5.49
PEG (5Y)N/A
Graham Number28.63
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.28% | ||
| ROE | -3.38% | ||
| ROCE | 6.94% | ||
| ROIC | 3.34% | ||
| ROICexc | 3.62% | ||
| ROICexgc | 5% | ||
| OM | 4.46% | ||
| PM (TTM) | N/A | ||
| GM | 32.49% | ||
| FCFM | 0.52% |
ROA(3y)1.56%
ROA(5y)6.94%
ROE(3y)4.15%
ROE(5y)12.76%
ROIC(3y)4.73%
ROIC(5y)10.19%
ROICexc(3y)5.21%
ROICexc(5y)12.96%
ROICexgc(3y)7.5%
ROICexgc(5y)19.19%
ROCE(3y)9.35%
ROCE(5y)16.79%
ROICexgc growth 3Y-45.93%
ROICexgc growth 5Y-23.4%
ROICexc growth 3Y-45.55%
ROICexc growth 5Y-25.45%
OM growth 3Y-27.03%
OM growth 5Y-9.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.37%
GM growth 5Y4.23%
F-Score5
Asset Turnover0.93
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 92.74 | ||
| Debt/EBITDA | 7.03 | ||
| Cap/Depr | 123.41% | ||
| Cap/Sales | 2.64% | ||
| Interest Coverage | 1.33 | ||
| Cash Conversion | 47.78% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.32 | ||
| Altman-Z | 1.82 |
F-Score5
WACC8.8%
ROIC/WACC0.38
Cap/Depr(3y)139.54%
Cap/Depr(5y)177.5%
Cap/Sales(3y)2.62%
Cap/Sales(5y)2.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-59.91%
EPS 3Y-54.22%
EPS 5Y-24.26%
EPS Q2Q%-116.67%
EPS Next Y5.9%
EPS Next 2Y39.26%
EPS Next 3Y50.07%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.01%
Revenue growth 3Y0.02%
Revenue growth 5Y8.87%
Sales Q2Q%-1.95%
Revenue Next Year1.95%
Revenue Next 2Y2.98%
Revenue Next 3Y3.37%
Revenue Next 5YN/A
EBIT growth 1Y-19.62%
EBIT growth 3Y-27.02%
EBIT growth 5Y-1%
EBIT Next Year25.8%
EBIT Next 3Y19.63%
EBIT Next 5YN/A
FCF growth 1Y113.87%
FCF growth 3Y-12.94%
FCF growth 5Y-47.23%
OCF growth 1Y383.73%
OCF growth 3Y-1.68%
OCF growth 5Y-24.9%
MARINEMAX INC / HZO FAQ
Can you provide the ChartMill fundamental rating for MARINEMAX INC?
ChartMill assigns a fundamental rating of 3 / 10 to HZO.
What is the valuation status of MARINEMAX INC (HZO) stock?
ChartMill assigns a valuation rating of 3 / 10 to MARINEMAX INC (HZO). This can be considered as Overvalued.
Can you provide the profitability details for MARINEMAX INC?
MARINEMAX INC (HZO) has a profitability rating of 3 / 10.
Can you provide the financial health for HZO stock?
The financial health rating of MARINEMAX INC (HZO) is 3 / 10.